Baseline characteristics of 233 CRPC patients based on initial dose of enzalutamide.

Figshare2021-10-01 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Baseline_characteristics_of_233_CRPC_patients_based_on_initial_dose_of_enzalutamide_/16723713 数据链接链接失效反馈

官方服务：

资源简介：

Baseline characteristics of 233 CRPC patients based on initial dose of enzalutamide.

创建时间：

2021-10-01

Systematic characterization of epigenetic modifying enzymes identifies KDM3B as a key regulator in castration resistant prostate cancer. Systematic characterization of epigenetic modifying enzymes identifies KDM3B as a key regulator in castration resistant prostate cancer

去势抵抗性前列腺癌

表观遗传靶点

Androgen deprivation therapy (ADT) is the standard care for prostate cancer patients who fail surgery and radiotherapy. While initially effective, the cancer almost always recurs into a more aggressiv

NIAID Data Ecosystem100

Nuclear ßArrestin1 Regulates Androgen Receptor Function in Castration Resistant Prostate Cancer. Nuclear ßArrestin1 Regulates Androgen Receptor Function in Castration Resistant Prostate Cancer

去势抵抗性前列腺癌

雄激素受体基因调控

We report that ßArrestin1 depletion inhibits androgen receptor function in canstration resistant prostate cancer cells. We used shcontrol and shßArr1 C4-2 cells for sequencing and analysed for androge

NIAID Data Ecosystem50

Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer

PROTAC药物开发

去势抵抗性前列腺癌

Castration-resistant prostate cancer (CRPC) remains a significant therapeutic challenge with limited effective treatment options. We identified retinoid X receptor γ (RXRγ) as a critical regulator of

Figshare2026-03-20 更新30

ARv7 represses tumor suppressors genes in castration-resistant prostate cancer [RNA-Seq]

去势抵抗性前列腺癌

转录抑制机制

Endocrine therapies in prostate cancer (PCa) treatment block androgen receptor (AR) function, but are palliative as tumors progress to a lethal, castration-resistant state (CRPC). CRPC remains depende

NIAID Data Ecosystem50

Human prostate cancer cells (VCaP and AIVCaP): siAR alone (single siRNA) vs. siAR plus OPRK1 (combo-siRNA)

去势抵抗性前列腺癌

OPRK1基因功能

Through comparative genomics using PDX models of androgen-dependent (AD) and castration-resistant (CR) tumors, we identify opioid receptor kappa 1 (OPRK1) as being associated with castration-resistanc

NIAID Data Ecosystem30

Baseline characteristics of 233 CRPC patients based on initial dose of enzalutamide.

资源简介：

相关数据集